May 11, 2020 / 12:39 PM / 15 days ago

BRIEF-Sarepta Therapeutics And Dyno Therapeutics Announce Agreement To Develop Next-Generation Gene Therapy Vectors For Muscle Diseases

May 11 (Reuters) - Sarepta Therapeutics Inc:

* SAREPTA THERAPEUTICS AND DYNO THERAPEUTICS ANNOUNCE AGREEMENT TO DEVELOP NEXT-GENERATION GENE THERAPY VECTORS FOR MUSCLE DISEASES

* SAREPTA THERAPEUTICS - AGREEMENT TO DEVELOP NEXT-GENERATION ADENO-ASSOCIATED VIRUS VECTORS FOR MUSCLE DISEASES, USING DYNO’S CAPSIDMAP PLATFORM

* SAREPTA THERAPEUTICS - DYNO WILL BE RESPONSIBLE FOR DESIGN AND DISCOVERY OF NOVEL AAV CAPSIDS

* SAREPTA THERAPEUTICS - IF SUCCESSFUL, DYNO COULD RECEIVE OVER $40 MILLION IN UPFRON

* SAREPTA THERAPEUTICS - DYNO WILL RECEIVE ROYALTIES ON WORLDWIDE NET SALES OF ANY COMMERCIAL PRODUCTS DEVELOPED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below